Bill number does not exist. Enter a vaild keyword.
Facebook Twitter Youtube Channels

Committee Testimony and Witness Signup

HB0737 - Public Health - Nonopioid Advance Directives

Health and Government Operations 2/19/2025 1:00:00 PM
As of: 6/25/2025 8:55:41 AM
Name Organization Position Testimony Committee
Delegate Bagnall, Delegate Bagnall FAV In Person - Oral Testimony
HGO
Geddes, Ann Mental Health Association of Maryland FAV HB0737_MHAMD_Fav.pdf HGO
Keller, Emily Maryland's Office of Overdose Response INFO HB737 - MOOR - LOI.docx.pdf HGO
Bagnall, Heather FAV In Person - Oral Testimony
HB737_FAV_Sponsor.pdf
HGO
Rosier, Collan Pyramid Healthcare, Inc. FAV No Testimony HGO
Fiastro, John FWA In Person - Oral Testimony
HGO
Lykins, Deana FWA In Person - Oral Testimony
HGO
Morhaim, Dan none UNF HB737 opposed.pdf HGO
Kauffman, Danna UNF HB0737_UNF_MedChi, MDACEP_PH - Nonopiod Advance Di HGO
Jordan, Dr. Rachel UNF In Person - Oral Testimony
HGO
Lowe, Lisa F.A.C.E. Addiction Maryland FAV Virtual - Oral Testimony
Association of Pharmaceutical Industry Marketing o
Opioids Market Size to Worth Around USD 26.78 Bill
Testimony - HB737 - Nonopioid Advance Directive.pd
HGO
Shimoda, Peggy Hospice & Palliative Care Network of Maryland UNF HB0737_UNF_HPCNM.pdf HGO
Torsch, Toni Daniel Carl Torsch Foundation FAV HB 737 - Favorable.pdf HGO
Click to return on the top page